These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 20978324)
1. The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival. Antonacopoulou AG; Floratou K; Bravou V; Kottorou A; Dimitrakopoulos FI; Marousi S; Stavropoulos M; Koutras AK; Scopa CD; Kalofonos HP Anal Cell Pathol (Amst); 2010; 33(5):177-89. PubMed ID: 20978324 [TBL] [Abstract][Full Text] [Related]
2. The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival. Antonacopoulou AG; Floratou K; Bravou V; Kottorou A; Dimitrakopoulos FI; Marousi S; Stavropoulos M; Koutras AK; Scopa CD; Kalofonos HP Cell Oncol (Dordr); 2011 Aug; 34(4):381-91. PubMed ID: 21538024 [TBL] [Abstract][Full Text] [Related]
3. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR. Pavlidou A; Dalamaga M; Kroupis C; Konstantoudakis G; Belimezi M; Athanasas G; Dimas K World J Gastroenterol; 2011 Mar; 17(12):1614-21. PubMed ID: 21472129 [TBL] [Abstract][Full Text] [Related]
4. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675 [TBL] [Abstract][Full Text] [Related]
5. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas. Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755 [TBL] [Abstract][Full Text] [Related]
6. Expression of survivin and its four splice variants in colorectal cancer and its clinical significances. Ge QX; Li YY; Nie YQ; Zuo WG; Du YL Med Oncol; 2013 Jun; 30(2):535. PubMed ID: 23494669 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population. Li XB; Li SN; Yang ZH; Cao L; Duan FL; Sun XW DNA Cell Biol; 2013 May; 32(5):236-42. PubMed ID: 23581553 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression. Sawicka-Gutaj N; Waligórska-Stachura J; Andrusiewicz M; Biczysko M; Sowiński J; Skrobisz J; Ruchała M Tumour Biol; 2015 Sep; 36(10):7859-63. PubMed ID: 25946974 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunohistochemical expression of survivin and its correlation with -31G/C gene polymorphism in colorectal cancer. Heidari Z; Sagheb HM; Hakimi A; Moudi B Med Mol Morphol; 2019 Jun; 52(2):82-89. PubMed ID: 30128768 [TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer. Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798 [TBL] [Abstract][Full Text] [Related]
12. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition. Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735 [TBL] [Abstract][Full Text] [Related]
13. The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer. Choi J; Chang H Anticancer Res; 2012 Feb; 32(2):559-64. PubMed ID: 22287745 [TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma. Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264 [TBL] [Abstract][Full Text] [Related]
15. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer. Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531 [TBL] [Abstract][Full Text] [Related]
17. Survivin expression impacts prognostically on NSCLC but not SCLC. Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of survivin splice variants in pituitary tumors. Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Kubiczak M; Jankowska A; Liebert W; Czarnywojtek A; Waśko R; Blanco-Gangoo AR; Ruchała M Pituitary; 2015 Jun; 18(3):410-6. PubMed ID: 25107550 [TBL] [Abstract][Full Text] [Related]
19. Expression of survivin and its significance in colorectal cancer. Chen WC; Liu Q; Fu JX; Kang SY World J Gastroenterol; 2004 Oct; 10(19):2886-9. PubMed ID: 15334693 [TBL] [Abstract][Full Text] [Related]
20. Role of survivin re-expression in the development and progression of non-small cell lung cancer. Javid J; Mir R; Julka PK; Ray PC; Saxena A Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]